News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website


2015 CNS Anticancer Drug Development and Delivery Conference

Al's Comment:

This is the announcement for an exciting conference the 2 days before the society of neurooncology conference.  It is for medical people only.

Posted on: 05/19/2015


PROPOSAL:  2015 CNS Anticancer Drug Development and Delivery Conference



Co-Sponsored by SNO and SCIDOT (Society for CNS Interstitial Delivery of Therapeutics)



·         Dates:  Wednesday and Thursday prior to SNO Annual Meeting  November 18-19, 2015 in San Antonio

o   General drug development and delivery talks, along with brain tumor applications scheduled on Wednesday and Thursday AM

o   Non-brain tumor application talks scheduled on Thursday PM

o   Reduces programmatic conflicts for SNO attendees

o   Allows for inclusion of non-brain tumor oriented speakers and attendees


·         Format:  Invited talks, abstracts for oral and poster presentation


·         Target Audience:

o   Clinical scientists

§  Neurosurgeons

§  NeuroOncologists

§  Neurologists (particularly movement disorders)

§  Medical Oncologists

§  Radiation Oncologists

§  Neuroradiologists (including Nuclear Medicine)

o   Laboratory and translational scientists focused on cancer, brain tumors, movement disorders, other neurological disorders and blood-brain-barrier physiology

o   Device manufacturers

o   Drug and biotechology manufacturers

o   Pre- and postdoctoral trainees


·         General Themes

o   Pharmacology and the impact of the BBB

o   Methods of performing direct and indirect pharmacokinetics and pharmacodynamics in the brain

o   Pharmacological approaches to improving therapeutic delivery to the brain and brain tumors

o   Intrathecal drug delivery

o   Drug delivery via intracavitary approaches

o   Convection enhanced drug delivery

§  Device development

§  Recent clinical trials for brain tumors

§  Recent clinical trials for non-neoplastic neurological disorders

o   Therapeutic development for direct brain delivery

§  Viral vectors

§  Conventional and target drugs

§  Carriers (nanoparticles and liposomes)

o   Clinical trial design and Regulatory considerations


·         Potential sponsors

o   Genentech

o   Brainlab

o   MRI Interventions

o   Alcyone

o   Infuseon Therapeutics

o   Renishaw

o   Armagen

o   Amgen

o   Biogen-Idec


Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557